CC chemokines

The Cytokine Handbook

Volumn , Issue , 2003, Pages 1083-1100

  Mantovani, Alberto ^a,b   Locati, Massimo ^b   Sozzani, Silvano ^a,c  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942863732     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012689663-3/50051-X     Document Type: Chapter

References (141)

1. Aliberti J., Reis e Sousa C., Schito M., et al. CCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells. Nat. Immunol. 2000, 1:83-87.
2. Allavena P., Sica A., Vecchi A., et al. The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues. Immunol. Rev. 2000, 177:141-149.
3. Baba M., Nishimura O., Kanzaki N., et al. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc. Natl Acad. Sci. USA 1999, 96:5698-5703.
4. Balentien E., Mufson B.E., Shattuck R.L., et al. Effects of MGSA/GRO alpha on melanocyte transformation. Oncogene 1991, 6:1115-1124.
5. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357:539-545.
6. Banchereau J., Briere F., Caux C., et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
7. Bandeira-Melo C., Bozza P.T., Diaz B.L., et al. Cutting edge: lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking. J. Immunol. 2000, 164:2267-2271.
8. Berger E.A., Murphy P.M., Farber J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 1999, 17:657-700.
9. Bonecchi R., Polentarutti N., Luini W., et al. Upregulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by interferon gamma in human neutrophils. J. Immunol. 1999, 162:474-479.
10. Boring L., Gosling J., Cleary M., Charo I.F. Decreased lesion formation in CCR2 -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998, 394:894-897.
11. Bottazzi B., Polentarutti N., Acero R., et al. Regulation of the macrophage content of neoplasms by chemoat-tractants. Science 1983, 220:210-212.
12. Bottazzi B., Ghezzi P., Taraboletti G., et al. Tumor-derived chemotactic factor(s) from human ovarian carcinoma: evidence for a role in the regulation of macrophage content of neoplastic tissues. Int. J. Cancer 1985, 36:167-173.
13. Bottazzi B., Colotta F., Sica A., et al. A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF). Int. J. Cancer 1990, 45:795-797.
14. Braun M.C., Lahey E., Kelsall B.L. Selective suppression of IL-12 production by chemoattractants. J. Immunol. 2000, 164:3009-3017.
15. Broxmeyer H.E., Cooper S., Hangoc G., et al. Dominant myelopoietic effector functions mediated by chemokine receptor CCR1. J. Exp. Med. 1999, 189:1987-1992.
16. Campbell J.J., Haraldsen G., Pan J., et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999, 400:776-780.
17. Cesarman E., Mesri E.A., Gershengorn M.C. Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia?. J. Exp. Med. 2000, 191:417-422.
18. Choi C., Xu X., Oh J.W., et al. Fas-induced expression of chemokines in human glioma cells: involvement of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase. Cancer Res. 2001, 61:3084-3091.
19. Cook D.N., Prosser D.M., Forster R., et al. CCR6 mediates dendritic cell localization, lymphocyte homeostasis and immune responses in mucosal tissue. Immunity 2000, 12:495-503.
20. Cossman J., Annunziata C.M., Barash S., et al. Reed-Sternberg cell genome expression supports a B-cell line-age. Blood 1999, 94:411-416.
21. Cyster J.G. Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J. Exp. Med. 1999, 189:447-450.
22. D'Amico G., Frascaroli G., et al. Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat. Immunol. 2000, 1:387-391.
23. DeMeester I., Korom S., Van Damme J., Scharpé S. CD26, let it cut or cut it down. Immunol. Today 1999, 20:367-375.
24. Dragic T., Trkola A., Thompson D.A., et al. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc. Natl Acad. Sci. USA 2000, 97:5639-5644.
25. Endres M.J., Garlisi C.G., Xiao H., et al. The Kaposi's sarcoma-related Herpes virus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8. J. Exp. Med. 1999, 189:1993-1998.
26. Fioretti F., Fradelizi D., Stoppacciaro A., et al. Reduced tumorigenicity and augmented leukocyte infiltration after MCP-3 gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor. J. Immunol. 1998, 161:342-346.
27. Fischer F.R., Luo Y., Luo M., et al. RANTES-induced chemokine cascade in dendritic cells. J. Immunol. 2001, 167:1637-1643.
28. Forbes I.T., Cooper D.G., Dodds E.K., et al. CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compound. Bioorg. Med. Chem. Lett. 2000, 10:1803-1806.
29. Förster R., Schubel A., Breitfeld D., et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999, 99:23-33.
30. Fraticelli P., Sironi M., Bianchi G., et al. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J. Clin. Invest. 2001, 107:1173-1181.
31. Furutani Y., Nomura H., Notake M., et al. Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). Biochem. Biophys. Res. Commun. 1989, 159:248-255.
32. Gao J.L., Wynn T.A., Chang Y., et al. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med. 1997, 185:1959-1968.
33. Gong J.H., Clark-Lewis I. Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2- terminal residues. J. Exp. Med. 1995, 181:631-640.
34. Gong J.H., Ratkay L.G., Waterfield J.D., Clark-Lewis I. An antagonist of monocyte chemoattractant protein-1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J. Exp. Med. 1997, 186:131-137.
35. Gosling J., Dairaghi D.J., Wang Y., et al. Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK. J. Immunol. 2000, 164:2851-2856.
36. Graves D.T., Jiang Y.L., Williamson M.J., Valente A.J. Identification of monocyte chemotactic activity produced by malignant cells. Science 1989, 245:1490-1493.
37. Gu L., Tseng S., Horner R.M., et al. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 2000, 404:407-411.
38. Gunn M.D., Kyuwa S., Tam C., et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 1999, 189:451-460.
39. Haghnegahdar H., Du J., Wang D., et al. The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma. J. Leukoc. Biol. 2000, 67:53-62.
40. Hess S., Smola H., Sandaradure De Silva U., et al. Loss of IL-6 receptor expression in cervical carcinoma cells inhibits autocrine IL-6 stimulation: abrogation of constitutive monocyte chemoattractant protein-1 production. J. Immunol. 2000, 165:1939-1948.
41. Hesselgesser J., Ng H.P., Liang M., et al. Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor. J. Biol. Chem. 1998, 273:15687-15692.
42. Horuk R., Colby T.J., Darbonne W.C., et al. The human erythrocyte inflammatory peptide (chemokine) receptor. Biochemical characterization, solubilization, and development of a binding assay for the soluble receptor. Biochemistry 1993, 32:5733-5738.
43. Huang M., Wang J., Lee P., et al. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res. 1995, 55:3847-3853.
44. Huang X.Q., Jiang H.L., Luo X.M., et al. Building three-dimensional structures of HIV-1 coreceptor CCR5 and its interaction with antagonist TAK779 by comparative molecular modeling. Acta Pharmacol. Sin. 2000, 21:521-528.
45. Huffnagle G.B., McNeil L.K., McDonald R.A., et al. Cutting edge: role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. J. Immunol. 1999, 163:4642-4646.
46. IUS/WHO Nomenclature Committee Chemokine/chemokine receptor nomenclature. J. Leukoc. Biol. 2001, 70:465-466.
47. Jiang Y., Beller D.I., Frendl G., Graves D.T. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J. Immunol. 1992, 148:2423-2428.
48. Jundt F., Anagnostopoulos I., Bommert K., et al. Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils. Blood 1999, 94:2065-2071.
49. Kanazawa N., Nakamura T., Tashiro K., et al. Fractalkine and macrophage-derived chemokine: T cell-attracting chemokines expressed in T cell area dendritic cells. Eur. J. Immunol. 1999, 29:1925-1932.
50. Kim J., Modlin R.L., Moy R.L., et al. IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J. Immunol. 1995, 155:2240-2247.
51. Kirk C.J., Hartigan-O'Connor D., Nickoloff B.J., et al. T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy. Cancer Res. 2001, 61:2062-2070.
52. Lambeir A.M., Proost P., Durinx C., et al. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking, selectivity within the chemokine family. J. Biol. Chem. 2001, 276:29839-29845.
53. Liang M., Rosser M., Ng H.P., et al. Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor. Eur. J. Pharmacol. 2000, 389:41-49.
54. Lloyd C.M., Dorf M.E., Proudfoot A., et al. Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis. J. Leukoc. Biol. 1997, 62:676-680.
55. Loetscher P., Dewald B., Baggiolini M., Seitz M. Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes. Effects of anti-rheumatic drugs. Cytokine 1994, 6:162-170.
56. Luboshits G., Shina S., Kaplan O., et al. Elevated expression of the CC chemokine RANTES in advanced breast carcinoma. Cancer Res. 1999, 59:4681-4687.
57. Luciani M.G., Stoppacciaro A., Peri G., et al. The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours. Mol. Pathol. 1998, 51:273-276.
58. Luther S.A., Cyster J.G. Chemokines as regulators of T cell differentiation. Nat. Immunol. 2001, 2:102-107.
59. Mackay C.R. Chemokines: immunology's high impact factors. Nat. Immunol. 2001, 2:95-101.
60. Maeda H., Shiraishi A. TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. J. Immunol. 1996, 156:73-78.
61. Maeda K., Yoshimura K., Shibayama S., et al. Novel low molecular weight spirodiketopiperazine derivatives potently inhibit R5 HIV-1 infection through their antagonistic effects on CCR5. J. Biol. Chem. 2001, 276:35194-35200.
62. Mantovani A. The chemokine system: redundancy for robust outputs. Immunol. Today 1999, 20:254-257.
63. Mantovani A., Bottazzi B., Colotta F., et al. The origin and function of tumor-associated macrophages. Immunol. Today 1992, 13:265-270.
64. Mantovani A., Dinarello C., Ghezzi P. Pharmacology of Cytokines 2000, Oxford University Press.
65. Mantovani A., Gray P.A., Van Damme J., Sozzani S. Macrophage-derived chemokine. J. Leukoc. Biol. 2000, 68:400-404.
66. Mantovani A., Locati M., Vecchi A., et al. Decoy receptors: a strategy, to regulate inflammatory cytokines and chemokines. Trends Immunol. 2001, 22:328-336.
67. Matloubian M., David A., Engel S., et al. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat. Immunol. 2000, 1:298-304.
68. Matsushima K., Larsen C.G., DuBois G.C., Oppenheim J.J. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 1989, 169:1485-1490.
69. Mazzucchelli L., Blaser A., Kappeler A., et al. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J. Clin. Invest. 1999, 104:R49-R54.
70. Meltzer M.S., Stevenson M.M., Leonard E.J. Characterization of macrophage chemotaxis in tumor cell cultures and comparison with lymphocyte-derived chemotactic factors. Cancer Res. 1977, 37:721-725.
71. Mirzadegan T., Diehl F., Ebi B., et al. Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding, to a common chemokine receptor motif within the helical bundle. J. Biol. Chem. 2000, 275:25562-25571.
72. Morales J., Homey B., Vicari A.P., et al. CTACK, a skin-associated chemokine that preferentially attracts skinhoming memory T cells. Proc. Natl Acad. Sci. USA 1999, 96:14470-14475.
73. Morimoto C., Schlossman S.F. The structure and function of CD26 in the T-cell immune response. Immunol. Rev. 1998, 161:55-70.
74. Moser B., Loetscher P. Lymphocyte traffic control by chemokines. Nat. Immunol. 2001, 2:123-128.
75. Mukaida N., Gussella G.L., Kasahara T., et al. Molecular analysis of the inhibition of interleukin-8 production by dexamethasone in a human fibrosarcoma cell line. Immunology 1992, 75:674-679.
76. Muller A., Homey B., Soto H., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
77. Murphy P.M., Baggiolini M., Charo I.F., et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 2000, 52:145-176.
78. Naya A., Sagara Y., Ohwaki K., et al. Design, synthesis, and discovery of a novel CCR1 antagonist. J. Med. Chem. 2001, 44(9):1429-1435.
79. Negus R.P., Stamp G.W., Relf M.G., et al. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J. Clin. Invest. 1995, 95:2391-2396.
80. Nesbit M., Schaider H., Miller T.H., Herlyn M. Low-level, monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma, cells. J. Immunol. 2001, 166:6483-6490.
81. Nibbs R.J., Kriehuber E., Ponath P.D., et al. The betachemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am. J. Pathol. 2001, 158:867-877.
82. Nokihara H., Yanagawa H., Nishioka Y., et al. Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice. Cancer Res. 2000, 60:7002-7007.
83. Nomura T., Hasegawa H., Kohno M., et al. Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI-1-ligand chemokine and stromal cell-derived factor-lalpha chemokine genes. Int. J. Cancer 2001, 91:597-606.
84. Opedenakker G., Van Damme J. Chemotactic factors, passive invasion and metastasis of cancer cells. Immunol. Today 1992, 13:463-464.
85. Panina-Bordignon P., Papi A., Mariani M., et al. The C-C chemokine receptors CCR4 and CCR8 identify aiway T cells of allergen-challenged atoptic asthmatics. J. Clin. Invest. 2001, 107:1357-1364.
86. Penna G., Sozzani S., Adorini L. Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J. Immunol. 2001, 167:1862-1866.
87. Penton-Rol G., Cota M., Polentarutti N., et al. Upregulation of CCR2 chemokine receptor expression and increased susceptibility to the multitrophic HIV strain 89.6 in monocytes exposed to glucocorticoid hormones. J. Immunol. 1999, 163:3524-3529.
88. Plater-Zyberk C., Hoogewerf A.J., Proudfoot A.E.I., et al. Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol. Lett. 1997, 57:117-120.
89. Poon M., Megyesi J., Green R.S., et al. In vivo and in vitro inhibition of JE gene expression by glucocorticoids. J. Biol. Chem. 1991, 266:22375-22379.
90. Power C.A., Church D.J., Meyer A., et al. Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3 alpha from lung dendritic cells. J. Exp. Med. 1997, 186:825-835.
91. Prest S.J., Rees R.C., Murdoch C., et al. Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials. Clin. Exp. Metastasis 1999, 17:389-396.
92. Proudfoot A.E., Power C.A., Wells T.N. The strategy of blocking the chemokine, system to, combat disease. Immunol. Rev. 2000, 177:246-256.
93. Riethdorf L., Riethdorf S., Gutzlaff K., et al. Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri. Am. J. Pathol. 1996, 149:1469-1476.
94. Rollins B.J. Chemokines'. Blood 1997, 90:909-928.
95. Rollins B.J., Morrison E.D., Stiles G.D. Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. Proc. Natl Acad. Sci. USA 1988, 85:3738-3742.
96. Roman M., Diomede L., Sironi M., et al. Inhibition of monocyte chemotactic protein-1 synthesis by statins. Lab. Invest. 2000, 80:1095-1100.
97. Rutledge B.J., Rayburn H., Rosenberg R., et al. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to inctracellular pathogens. J. Immunol. 1995, 155:4838-4843.
98. Sabroe I., Peck M.J., Van Keulen B.J., et al. A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of ecosinophil function and CCR3-mediated HIV-1 entry. J. Biol. Chem. 2000, 275:25985-25992.
99. Sallusto F., Schaerli P., Hortscher P., et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 1998, 28:2760-2769.
100. Sallusto F., Lenig D., Förster R., et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
101. Sallusto F., Mackay C.R., Lanzavecchia A. The role of chemokine receptors in primary,; effector, and memory immune reresponses. Annu. Rev. Immunol. 2000, 18:593-620.
102. Samson M., Edinger A.L., Stordeur P., et al. ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a correceptor for SIV and some primary HIV-1 strains. Eur. J. Immunol. 1998, 28:1689-1700.
103. Schutyser E., Struyf S., Proost P., et al. Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/PARC in ovarian carcinoma. J. Biol. Chem. 2002, 277:24584-24593.
104. Sciacca F.L., Stürzl M., Bussolino F., et al. Expression of adhesion molecules, platelet-activating factor, and chemokines by Kaposi's sarcoma cells. J. Immunol. 1994, 153:4816-4825.
105. Scotton C.J., Wilson J.L., Milliken D., et al. Epithelial cancer cell migration: a role for chemokine receptors?. Cancer Res. 2001, 61:4961-4965.
106. Sica A., Saccani A., Borsatti A., et al. Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J. Exp. Med. 1997, 185:969-974.
107. Sica A., Saccani A., Bottazzi B., et al. Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma. J. Immunol. 2000, 164:733-738.
108. Sica A., Saccani A., Bottazzi B., et al. Autocrine production of IL-10 mediates defective IL-12 production and NF-kB activation in tumor-associated macrophages. J. Immunol. 2000, 164:762-767.
109. Simmons G., Clapham P.R., Picard L., et al. Potent HIV inhibition of HIV infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 1997, 276:276-279.
110. Singh P.K., Gutman M., Radinsky R., et al. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res. 1994, 54:3242-3247.
111. Sironi M., Gulielmotti A., Polentaruti N., et al. A small synthetic molecule capable of preferentially inhibiting the production of the CC chemokine monocyte chemotactic protein-1. Eur. Cytokine Netw. 1999, 10:437-442.
112. Snyderman R., Cianciolo G.J. Immuno-suppressive activity of the retroviral envelope protein P15E and its possible relationship to neoplasia. Immunol. Today 1984, 5:240-244.
113. Sodhi A., Montaner S., Patel V., et al. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor lalpha. Cancer Res. 2000, 60:4873-4880.
114. Sozzani, S., Allavena, P., Proost, P. et al. Chemokines as targets for pharmacological intervention. In: Jucker, E. (ed.) Basel: Progress in Drug, Research. Birkhafser Verlag, pp. 53-80.
115. Sozzani S., Ghezzi S., Iannolo G., et al. Interleukin-10 increases CCR5 expression and HIV infection in human monocytes. J. Exp. Med. 1998, 187:439-444.
116. Sozzani S., Luini W., Bianchi G., et al. The viral, chemokine macrophage inflammatory protein-II is a selective Th2 chemoattactant. Blood 1998, 92:4036-4039.
117. Stine J.T., Wood C., Hill M., et al. KSHV-encoded Cc chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts th2 cells. Blood 2000, 95:1151-1157.
118. Struyf S., Menten P., Lenaerts J.P., et al. Diverging binding capacitie of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophil. Rur. J. Immunol. 2001, 31:2170-2178.
119. Tagat J.R., McCombie S.W., Steensma R.W., et al. Piprazine-based CCR5 antagonists as HIV-1 inhibitors. I: 2(S)-methyl piperazine as a key pharmacophore element. Bioorg. Med. Chem. Lett. 2001, 11:2143-2146.
120. Valente A.J., Fowler S.R., Sprague E.A., et al. Initial characterization of a paripheral blood mononuclear cell chemoattractant derived from cultued arterial smooth muscle cells. Am. J. Pathol. 1984, 117:409-417.
121. Valkovic T., Lucin K., Krstulja M., et al. Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer. Pathol. Res. Pract. 1998, 194:335-340.
122. Van Damme J., Decock B., Lenaerts J.P., et al. Identification by sequence analysis of chemotactic factors for monocytes produced by normal and transformed cells stimulated with virus, double-standed RNA or cytokine. Eur. J. Immunol. 1989, 19:2367-2373.
123. Van Damme J., Struyf S., Wuyts A., et al. The role of CD26/DPP IV in chemokine processing. Chem. Immunol. 1999, 72:42-56.
124. van den Berg A., Visser L., Poppema S. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma. Am. J. Pathol. 1999, 154:1685-1691.
125. Vicari A.P., Ait-Yahia S., Chemin K., et al. Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms. J. Immunol. 2000, 165:1992-2000.
126. Vissers J.L., Hartgers F.C., Lindhou E., et al. BLC (CXCL13) is expressed by different dendritic cell subsets in vitro and in vivo. Eur. J. Immunol. 2001, 31:1544-1549.
127. Vulcano M., Albanesi C., Stoppacciaro A., et al. Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur. J. Immunol. 2001, 31:812-822.
128. Wang J.M., Chertov O., Proost P., et al. Purification and identification of chemokines potentially involved in kidney-specific metastasis by a murine lymphoma variant: induction of migration and NFkB activation. Int. J. Cancer 1998, 75:900-907.
129. Wang J.M., Taraboletti G., Matsushima K., et al. Induction of heptotatic migration of melanoma cells by neutrophil activating protein/interleukin-8. Biochem. Biophys. Res. Commun. 1990, 169:165-170.
130. Weber K.S., Grone H.J., Rocken M., et al. Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II. Eur. J. Immunol. 2001, 31:2458-2466.
131. Wertheim W.A., Kunkel S.L., Standiford T.J., et al. Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. J. Immunol. 1993, 151:2166-2175.
132. White J.R., Lee J.M., Dede K., et al. Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration. J. Biol. Chem. 2000, 275:36626-36631.
133. Wurbel M.A., Malissen M., Guy-Grand D., et al. Mice lacking the CCR9 CC-chemokine receptor show a mild impairments of early T- and B-cell development and a reduction in T-cell receptor gammadelta(+) gut intraepithelial lymphocytes. Blood 2001, 98:2626-2632.
134. Yang D., Chen Q., Chertov O., Oppenheim J.J. Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J. Leukoc. Biol. 2000, 68:9-14.
135. Yang T.Y., Chen S.C., Leach M.W., et al. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J. Exp. Med. 2000, 191:445-454.
136. Yoshimura T., Robinson E.A., Tanaka S., et al. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J. Exp. Med. 1989, 169:1449-1459.
137. Yoshimura T., Yuhki N., Moore S.K., et al. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulation blood mononuclear leukocytes, and sequence similirity to mouse competence gene JE. FEBS Lett. 1989, 244:487-493.
138. Zachariae C.O., Anderson A.O., Thompson H.L., et al. Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J. Exp. Med. 1990, 171:2177-2182.
139. Zipfel P.F., Bialonski A., Skerka C. Induction of members of the IL-8/NAP-1 gene family in human T lymphocytes is suppressed by cyclosporin A. Biochem. Biophys. Res. Commun. 1991, 181:179-183.
140. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127.
141. Zullo J.N., Cochran B.H., Huang A.S., Stiles C.D. Platelet-derived growth factor and double-stranded ribonucleic acids stimulate expression of the same genes in 3T3 cells. Cell 1985, 43:793-800.